➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
McKesson
Express Scripts
McKinsey
Colorcon
Mallinckrodt

Last Updated: May 13, 2021

DrugPatentWatch Database Preview

Watson Labs Inc Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for WATSON LABS INC, and what generic and branded alternatives to WATSON LABS INC drugs are available?

WATSON LABS INC has seventy-seven approved drugs.

There are eleven tentative approvals on WATSON LABS INC drugs.

Summary for Watson Labs Inc
US Patents:0
Tradenames:62
Ingredients:62
NDAs:77

Drugs and US Patents for Watson Labs Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs Inc PENICILLIN G POTASSIUM penicillin g potassium INJECTABLE;INJECTION 062991-001 Sep 13, 1988 DISCN No No   Get Started for $10   Get Started for $10
Watson Labs Inc SOLIFENACIN SUCCINATE solifenacin succinate TABLET;ORAL 202551-001 May 20, 2019 AB RX No No   Get Started for $10   Get Started for $10
Watson Labs Inc ROPINIROLE HYDROCHLORIDE ropinirole hydrochloride TABLET, EXTENDED RELEASE;ORAL 200431-001 Jun 6, 2012 DISCN No No   Get Started for $10   Get Started for $10
Watson Labs Inc PROPOFOL propofol INJECTABLE;INJECTION 205307-001 Dec 22, 2015 AB RX No No   Get Started for $10   Get Started for $10
Watson Labs Inc SOLIFENACIN SUCCINATE solifenacin succinate TABLET;ORAL 202551-002 May 20, 2019 AB RX No No   Get Started for $10   Get Started for $10
Watson Labs Inc VALSARTAN valsartan TABLET;ORAL 090642-004 Jan 5, 2015 DISCN No No   Get Started for $10   Get Started for $10
Watson Labs Inc NEBIVOLOL HYDROCHLORIDE nebivolol hydrochloride TABLET;ORAL 203683-004 Nov 27, 2015 DISCN No No   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Colorcon
McKesson
Moodys
Boehringer Ingelheim
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.